CLINICAL_TRIALS
trial_result
· 2023-12-15
Clinical Trial Update: A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Summary
Phase 3 trial of ABP 654 for moderate to severe plaque psoriasis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2023-12-15